MMM

3M Company (3M CO) - 10-Q Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended June 30, 2003. 3M operates globally in over 60 countries, deriving more than half of its revenues from outside the United States. Effective January 1, 2003, the company realigned its reporting structure into seven business segments: Health Care, Industrial, Consumer and Office, Display and Graphics, Electro and Communications, Safety, Security and Protection Services, and Transportation. On August 11, 2003, the Board declared a two-for-one stock split to be distributed on September 29, 2003; financial data in this filing is presented on a pre-split basis.

Key Financial Metrics (Six Months Ended June 30, 2003)

*Free Cash Flow calculated as Net Cash from Operating Activities less Purchases of Property, Plant and Equipment.

Material Changes vs. Prior Period

• Sales Growth: Worldwide sales increased 10.5% year-over-year, driven by a 5.5% volume increase (3.6% core, 1.9% acquisitions) and a 5.1% positive currency translation impact. International sales grew 18.2%, while U.S. sales grew 1.4%.
• Profitability: Operating margins expanded significantly due to higher sales volumes, productivity gains from Six Sigma initiatives, and the absence of the $202 million restructuring charges incurred in the first half of 2002.
• Special Items: The first half of 2003 included a $93 million pre-tax charge related to an adverse court ruling in the LePage's Inc. antitrust lawsuit. This contrasts with the first half of 2002, which included $202 million in restructuring charges.
• Acquisitions: The company spent $424 million on acquisitions, primarily the purchase of an additional 25% interest in Sumitomo 3M Limited ($377 million) and the finalization of the Corning Precision Lens acquisition.

Guidance, Outlook, and Risks

• Outlook: Management expects the worldwide effective income tax rate to remain in the 33% range for the remainder of 2003 due to taxes associated with repatriating cash. Capital expenditures are projected to total $750 million to $800 million for the full year 2003.
• Dividends: The quarterly dividend was increased by 6.5% to $0.66 per share in February 2003, marking the 45th consecutive annual increase.
• Legal Risks: Significant contingencies include the LePage's antitrust litigation (Supreme Court review pending), respirator mask/asbestos litigation (approx. 82,700 claims), and breast implant insurance recovery litigation. The company has accrued $211 million in liabilities and $357 million in receivables for asbestos/respirator matters.
• Market Risks: The company faces risks from foreign currency fluctuations, global economic conditions, and the potential impact of the SARS outbreak on downstream demand.

Investor Verification Checklist

• Stock Split Impact: Verify that all per-share metrics (EPS, dividends) are adjusted for the two-for-one split effective September 29, 2003, when comparing to future reports.
• LePage's Litigation: Monitor the outcome of the U.S. Supreme Court petition regarding the LePage's antitrust ruling, which resulted in a $93 million charge.
• Asbestos/Respirator Exposure: Review the trend in claim volumes and the adequacy of the $211 million liability accrual versus the $357 million insurance receivable.
• Segment Performance: Note the divergence in segment performance; Display and Graphics and Safety/Security showed strong growth, while Electro and Communications faced volume declines due to telecom industry weakness.
• Currency Sensitivity: Assess the impact of the weaker U.S. dollar, which contributed significantly to sales and earnings growth, and how a strengthening dollar might affect future results.